Results 51 to 60 of about 478,591 (193)
The evidence and the rationale for the use of honey as wound dressing [PDF]
, 2011 Although there are now several brands and types of honey wound-care products available as registered medical devices, there is little promotional advertising of honey products for wound care. The misconception that there is no evidence to support the use
Molan, Peter C.
core +1 more source
Evaluation of anti-ulcer activity of Ardisia crispa Thunb. D.C [PDF]
, 2009 Ardisia crispa Thunb D.C (Myrsinaceae), has long been used in treating various ailments among the local villagers. The objective of this study was to investigate experimentally the possible anti-ulcer activity of Ardisia crispa.
Abd Hamid @ Abdul Razak, Roslida +2 more
core
[The search for anti-ulcer agents at IDR].
Acta pharmaceutica Hungarica, 2002 2-Pyridyl-thioacetamide (2-PTA) was synthesized at IDR in 1968. This molecule showed strong antiulcer/antisecretory effects in animals and man by inhibiting the proton pump. Based on our work Astra developed omeprazole which is the No. 1 drug in the world from 1996. 2-PTA remained a very popular template for drug design for a quarter of century.
openaire +1 more source
Risk factors in gastric cancer [PDF]
, 2010 STATE OF THE ART: Gastric cancer (GC) is still a major health problem worldwide due to its frequency, poor prognosis and limited treatment options. At present prevention is likely to be the most effective means of reducing the incidence and mortality ...
COMPARE, DEBORA +2 more
core
Prevention of Dabigatran-Related Gastrointestinal Bleeding With Gastroprotective Agents: A Population-Based Study [PDF]
, 2015 BACKGROUND & AIMS: Use of dabigatran, an inhibitor of thrombin, increases the risk of gastrointestinal bleeding (GIB). However, it is not clear whether gastroprotective agents (GPAs) prevent GIB in dabigatran users.
Chan, EW +6 more
core
Intravenous meloxicam for the treatment of moderate to severe acute pain: a pooled analysis of safety and opioid-reducing effects. [PDF]
, 2019 BACKGROUND AND OBJECTIVES: To describe the safety and tolerability of intravenous meloxicam compared with placebo across all phase II/III clinical trials.
Bergese, Sergio +7 more
core +1 more source
Effect of the enzymatic inhibitor of Kunitz on the gastric lesions from reserpine, from phenylbutazone, from pyloric ligation and by restraint in the rat [PDF]
The protective effects of certain polypeptides on gastric ulcerations caused from reserpine and phenylbutazone in the rate were studied. It was found that the Kunitz enzymatic inhibitor exerts a protective action in regard to gastric lesions.
Bel, C. +3 more
core +1 more source
Anti-ulcer and anti-secretory effects of SU-840, a novel anti-ulcer agent.
Japanese Journal of Pharmacology, 1994 Yoshihiko Isobe +4 more
openaire +1 more source